Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 293 insiders at 194 companies
- $6.3B sold by 282 insiders outside a trading plan
- $3.3B sold by 627 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.4M 18,000 shares at $75.51 1.4% of stakeTraded Oct 2–6 Filed Oct 6
-
Fred Joseph Deutsch DirectorFCCOFirst Community CorporationSale$15 0 shares at $32.57 <0.1% of stakeTraded Oct 5 Filed Oct 6
-
Barry J. Simon DirectorIBRXImmunityBio, Inc.Planned sale$269K 25,000 shares at $10.75 0.9% of stakeTraded Oct 5 Filed Oct 6
-
Cheryl Cohen DirectorIBRXImmunityBio, Inc.Planned sale$851K 81,056 shares at $10.50 45% of stakeTraded Oct 2 Filed Oct 6
-
Peter Greenleaf DirectorPTHSPelthos Therapeutics Inc.Planned sale$17K 797 shares at $21.17 3.3% of stakeTraded Oct 2 Filed Oct 6
-
Ezra M Friedberg DirectorPTHSPelthos Therapeutics Inc.Planned sale$12K 558 shares at $20.72 0.7% of stakeTraded Oct 2 Filed Oct 6
-
Matthew Pauls DirectorPTHSPelthos Therapeutics Inc.Planned sale$17K 786 shares at $21.00 5.5% of stakeTraded Oct 2 Filed Oct 6
-
Yvonne Wassenaar DirectorRBRKRubrik, Inc.Planned sale$86K 721 shares at $119.00 19% of stakeTraded Oct 5 Filed Oct 6
-
Raanan Zilberman DirectorVSHVishay Intertechnology, Inc.Planned sale$594K 16,575 shares at $35.82 34% of stakeTraded Oct 2 Filed Oct 6
-
Corinna Lathan DirectorPTCPTC Inc.Planned sale$343K 1,750 shares at $195.75 21% of stakeTraded Oct 5 Filed Oct 6
-
Eugene A Scherbakov DirectorIPGPIPG Photonics CorporationPlanned sale$260K 3,048 shares at $85.30 6.3% of stakeTraded Oct 2 Filed Oct 6
-
Douglas A Alexander DirectorAMKRAmkor Technology, Inc.Planned sale$275K 5,000 shares at $55.00 15% of stakeTraded Oct 2 Filed Oct 6
-
Steven Schuurman DirectorESTCElastic N.V.Sale$135M 1,500,000 shares at $90.13 25% of stakeTraded Oct 5 Filed Oct 6
-
Carrie Palin DirectorNTAPNetApp, Inc.Sale$1.1M 5,000 shares at $216.43 43% of stakeTraded Oct 2 Filed Oct 6
-
Michael J Kasbar ChairWKCWorld Kinect CorporationPlanned sale$357K 10,000 shares at $35.67 1% of stakeTraded Oct 2 Filed Oct 6
-
Amy Guggenheim Shenkan DirectorRNGRingCentral, Inc.Planned sale$100K 1,264 shares at $78.89 4.3% of stakeTraded Oct 2 Filed Oct 6
-
Amar K. Goel ChairPUBMPubMatic, Inc.Planned sale$201K 10,795 shares at $18.66 23% of stakeTraded Oct 5 Filed Oct 6
-
Gokul Rajaram DirectorPINSPinterest, Inc.Planned sale$21K 1,050 shares at $20.00 2.8% of stakeTraded Oct 5 Filed Oct 6
-
Stanley Tang DirectorDASHDoorDash, Inc.Planned sale$4.3M 23,125 shares at $186.19 69% of stakeTraded Oct 2 Filed Oct 6
-
Keith R Larson DirectorNWPXNWPX Infrastructure, Inc.Planned sale$27K 250 shares at $106.48 1.7% of stakeTraded Oct 5 Filed Oct 6
-
Debra Zumwalt DirectorHURNHuron Consulting Group Inc.Planned sale$14K 82 shares at $167.75 0.3% of stakeTraded Oct 2 Filed Oct 6
-
Charles Kane DirectorSYMSymbotic Inc.Planned sale$86K 2,000 shares at $43.17 2.2% of stakeTraded Oct 1 Filed Oct 5
-
Gerald Held DirectorNTAPNetApp, Inc.Sale$1.2M 5,757 shares at $212.00 36% of stakeTraded Oct 1 Filed Oct 5
-
Lauren Elaina Friedman Stat DirectorPLTRPalantir Technologies Inc.Planned sale$254K 1,337 shares at $189.95 2.5% of stakeTraded Oct 1 Filed Oct 5
-
Sameer K Gandhi DirectorCRWDCrowdStrike Holdings, Inc.Planned sale$14.3M 54,000 shares at $265.22 1.9% of stakeTraded Oct 1 Filed Oct 5
-
Mark B Templeton DirectorANETArista Networks, Inc.Planned sale$1M 5,000 shares at $204.37 9.4% of stakeTraded Oct 1 Filed Oct 5
-
Timothy D Cook ChairAAPLApple Inc ComPlanned sale$63.8M 191,753 shares at $332.96 5.5% of stakeTraded Oct 2 Filed Oct 5
-
Daniel Masters DirectorCSHRCoinShares PLCPlanned sale$492K 100,000 shares at $4.92 0.5% of stakeTraded Oct 1–5 Filed Oct 5
-
Neil D Hunt DirectorROKURoku, Inc.Planned sale$302K 2,000 shares at $151.09 17% of stakeTraded Oct 1 Filed Oct 5
-
Melissa B Epperly DirectorROIVRoivant Sciences Ltd.Planned sale$641K 17,750 shares at $36.10 54% of stakeTraded Oct 1 Filed Oct 5
-
Jeffrey W Dunn DirectorSIBNSI-BONE, Inc.Planned sale$369K 20,000 shares at $18.47 56% of stakeTraded Oct 1 Filed Oct 5
-
Christopher M Starr DirectorMNPRMonopar Therapeutics Inc.Planned sale$659K 8,400 shares at $78.50 62% of stakeTraded Oct 1 Filed Oct 5
-
Marc L Andreessen DirectorCOINCoinbase Global, Inc.Planned sale$3.9M 20,514 shares at $190.12 1.8% of stakeTraded Oct 1–2 Filed Oct 5
-
John Philip Coghlan DirectorLIFLife360, Inc.Planned sale$161K 4,000 shares at $40.37 24% of stakeTraded Oct 1 Filed Oct 5
-
Ori Winitzer DirectorLCIDLcidPlanned sale$4,120 1,000 shares at $4.12 1.5% of stakeTraded Oct 1 Filed Oct 5
-
Vincentelli Alberto Sangiovanni DirectorCDNSCadence Design Systems, Inc.Planned sale$438K 1,250 shares at $350.07 3.1% of stakeTraded Oct 1 Filed Oct 5
-
Frederic Simon DirectorFROGJFrog Ltd.Planned sale$11.7M 120,000 shares at $97.24 4.2% of stakeTraded Oct 1 Filed Oct 5
-
J. Scott Garland DirectorELVNEnliven Therapeutics, Inc.Sale$607K 13,000 shares at $46.67 100% of stakeTraded Oct 1 Filed Oct 5
-
Noel Joseph Spiegel DirectorAEOAmerican Eagle Outfitters, Inc.Sale$64K 3,617 shares at $17.68 100% of stakeTraded Oct 2 Filed Oct 5
-
Josh Silverman ChairETSYEtsyPlanned sale$151K 2,090 shares at $72.45 0.8% of stakeTraded Oct 1 Filed Oct 5
-
Dianne Ledingham DirectorPEGAPegasystems Inc.Planned sale$34K 1,000 shares at $34.15 2.5% of stakeTraded Oct 1 Filed Oct 5
-
Bruce C Cozadd DirectorJAZZJazz Pharmaceuticals plcPlanned sale$1.4M 6,000 shares at $230.33 1.7% of stakeTraded Oct 1 Filed Oct 5
-
Andy Fang DirectorDASHDoorDash, Inc.Planned sale$918K 5,000 shares at $183.69 100% of stakeTraded Oct 1 Filed Oct 5
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$6.9M 500,000 shares at $13.87 6.6% of stakeTraded Oct 1–2 Filed Oct 5
-
Kira Scherer Wampler DirectorDOCSDoximity, Inc.Planned sale$58K 2,000 shares at $28.91 6.7% of stakeTraded Oct 1 Filed Oct 5
-
Tomas Braun DirectorGGALGrupo Financiero Galicia S.A.Sale$188K 39,562 shares at $4.75 13% of stakeTraded Mar 20–Sep 14 Filed Oct 5
-
Eric F. Cosentino DirectorIDTIDT CorporationSale$39K 500 shares at $78.55 93% of stakeTraded Oct 1 Filed Oct 5
-
Charles Kissner DirectorRMBSRambus, Inc.Planned sale$555K 5,000 shares at $111.00 57% of stakeTraded Oct 2 Filed Oct 5
-
Michael L Speiser DirectorSNOWSnowflake Inc.Planned sale$17.5M 50,741 shares at $344.00Traded Oct 2 Filed Oct 2
-
Mary Agnes Wilderotter DirectorDOCUDocuSign, Inc.Planned sale$69K 1,000 shares at $68.80 31% of stakeTraded Oct 1 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.